Clinical trials
Phase 3 Stomatitis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
36 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 3 |
| 2006 | 1 |
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 3 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 5 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2023 | 4 |
| 2024 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 21 |
| Unknown status | 6 |
| Recruiting | 3 |
| Terminated | 3 |
| Withdrawn | 1 |
| Not yet recruiting | 1 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amgen | 2 |
| Cairo University | 2 |
| Instituto Nacional de Cancer, Brazil | 2 |
| Swedish Orphan Biovitrum | 2 |
| Air Force Military Medical University, China | 1 |
| All India Institute of Medical Sciences | 1 |
| Biotec Pharmacon ASA | 1 |
| Centre Leon Berard | 1 |
| Daewoong Pharmaceutical Co. LTD. | 1 |
| Endo USA Inc., a Keenova Therapeutics Company | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Stomatitis | 36 |
| Head and Neck Neoplasms | 10 |
| Mucositis | 5 |
| Neoplasms | 5 |
| Carcinoma, Squamous Cell | 4 |
| Ulcer | 3 |
| Oral Ulcer | 2 |
| Radiation Injuries | 2 |
| Squamous Cell Carcinoma of Head and Neck | 2 |
| Bone Marrow Neoplasms | 1 |
Trials
Showing 26 to 36 of 36. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.